Organización Sanitaria Integrada Araba
Osakidetza Organization
GlaxoSmithKline (Spain)
Madrid, EspañaPublications in collaboration with researchers from GlaxoSmithKline (Spain) (7)
2019
-
Budget impact analysis of subcutaneous belimumab in patients with systemic lupus erythematosus in Spain
ClinicoEconomics and Outcomes Research, Vol. 11, pp. 757-765
2011
-
Pharmacokinetic/pharmacodynamic evaluation of amoxicillin, amoxicillin/clavulanate and ceftriaxone in the treatment of paediatric acute otitis media in Spain
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. 3, pp. 167-173
2009
-
Impact of acute otitis media pathogen shifts on the clinical efficacy of several antibiotics: A therapeutic outcomes model
Journal of Chemotherapy, Vol. 21, Núm. 4, pp. 408-413
2008
-
Low rate of adverse hepatic events associated with fosamprenavir/ritonavir-based antiretroviral regimens
HIV Clinical Trials, Vol. 9, Núm. 5, pp. 309-313
2007
-
What are the most appropriate antibiotics for the treatment of acute exacerbation of chronic obstructive pulmonary disease? A therapeutic outcomes model
Journal of Antimicrobial Chemotherapy, Vol. 60, Núm. 3, pp. 605-612
2005
-
Evaluation of antimicrobial treatments in children with acute otitis media in Spain: A pharmacokinetic-pharmacodynamic (PK/PD) approach
Journal of Chemotherapy, Vol. 17, Núm. 6, pp. 628-635
2003
-
Evaluación psicométrica comparativa de las versiones en español de 6, 17 y 21 ítems de la Escala de valoración de Hamilton para la evaluación de la depresión
Medicina Clinica, Vol. 120, Núm. 18, pp. 693-700